DOI QR코드

DOI QR Code

Inhibitory effects of ginsenosides on basic fibroblast growth factor-induced melanocyte proliferation

  • Lee, Ji Eun (Department of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University) ;
  • Park, Jong Il (Department of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University) ;
  • Myung, Cheol Hwan (Department of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University) ;
  • Hwang, Jae Sung (Department of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University)
  • Received : 2016.01.29
  • Accepted : 2016.05.04
  • Published : 2017.07.15

Abstract

Background: UV-B-exposed keratinocytes secrete various paracrine factors. Among these factors, basic fibroblast growth factor (bFGF) stimulates the proliferation of melanocytes. Ginsenosides, the major active compounds of ginseng, are known to have broad pharmacological effects. In this study, we examined the antiproliferative effects of ginsenosides on bFGF-induced melanocyte proliferation. Methods: We investigated the inhibitory effects of Korean Red Ginseng and ginsenosides from Panax ginseng on bFGF-induced proliferation of melan-a melanocytes. Results: When melan-a melanocytes were treated with UV-B-irradiated SP-1 keratinocytes media, cell proliferation increased. This increased proliferation of melanocytes decreased with a neutralizing anti-bFGF antibody. To elucidate the effects of ginsenosides on melanocyte proliferation induced by bFGF, we tested 15 types of ginsenoside compounds. Among them, Rh3, Rh1, F1, and CK demonstrated antiproliferative effects on bFGF-induced melanocyte proliferation after 72 h of treatment. bFGF stimulated cell proliferation via extracellular signal-regulated kinase (ERK) activation in various cell types. Western blot analysis found bFGF-induced ERK phosphorylation in melan-a. Treatment with Rh3 inhibited bFGF-induced maximum ERK phosphorylation and F1-delayed maximum ERK phosphorylation, whereas Rh1 and CK had no detectable effects. In addition, cotreatment with Rh3 and F1 significantly suppressed bFGF-induced ERK phosphorylation. Western blot analysis found that bFGF increased microphthalmia-associated transcription factor (MITF) protein levels in melan-a. Treatment with Rh3 or F1 had no detectable effects, whereas cotreatment with Rh3 and F1 inhibited bFGF-induced MITF expression levels more strongly than a single treatment. Conclusion: In summary, we found that ginsenosides Rh3 and F1 have a synergistic antiproliferative effect on bFGF-induced melan-a melanocyte proliferation via the inhibition of ERK-mediated upregulation of MITF.

Keywords

References

  1. Choi S, Park Y, Lee S, Kim J, Chung M. Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol 2002;27:513-5. https://doi.org/10.1046/j.1365-2230.2002.01120.x
  2. Boissy RE. Melanosome transfer to and translocation in the keratinocyte. Exp Dermatol 2003;12:5-12. https://doi.org/10.1034/j.1600-0625.12.s2.1.x
  3. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature 2007;445:843-50. https://doi.org/10.1038/nature05660
  4. Perez-Bernal A, Munoz-Perez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol 2000;1:261-8. https://doi.org/10.2165/00128071-200001050-00001
  5. Ortonne JP. The effects of ultraviolet exposure on skin melanin pigmentation. J Int Med Res 1990;18:8C-17C. https://doi.org/10.1177/03000605900180S103
  6. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children: similarities to melanoma: the vancouver mole study. Arch Dermatol 1990;126:770-6. https://doi.org/10.1001/archderm.1990.01670300070010
  7. Yamaguchi Y, Takahashi K, Zmudzka BZ, Kornhauser A, Miller SA, Tadokoro T, Berens W, Beer JZ, Hearing VJ. Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. FASEB J 2006;20:1486-8. https://doi.org/10.1096/fj.06-5725fje
  8. Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005;18:2-12. https://doi.org/10.1111/j.1600-0749.2004.00198.x
  9. Romero-Graillet C, Aberdam E, Clement M, Ortonne JP, Ballotti R. Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest 1997;99:635-42. https://doi.org/10.1172/JCI119206
  10. Ansel JC, Luger TA, Lowry D, Perry P, Roop DR, Mountz JD. The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol 1988;140:2274-8.
  11. Chung JH, Youn SH, Koh WS, Eun HC, Cho KH, Park KC, Li Youn J. Ultraviolet B irradiation-enhanced interleukin (IL)-6 production and mRNA expression are mediated by IL-1a in cultured human keratinocytes. J Invest Dermatol 1996;106:715-20. https://doi.org/10.1111/1523-1747.ep12345608
  12. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990;172:1609-14. https://doi.org/10.1084/jem.172.6.1609
  13. Gallo RL, Staszewski R, Sauder DN, Knisely TL, Granstein RD. Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation. J Invest Dermatol 1991;97:203-9. https://doi.org/10.1111/1523-1747.ep12479676
  14. Hara M, Yaar M, Gilchrest BA. Endothelin-1 of keratinocyte origin is a mediator of melanocyte dendricity. J Invest Dermatol 1995;105:744-8. https://doi.org/10.1111/1523-1747.ep12325522
  15. Funasaka Y, Chakraborty A, Hayashi Y, Komoto M, Ohashi A, Nagahama M, Inoue Y, Pawelek J, Ichihashi M. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-$1{\alpha}$, interleukin-$1{\beta}$, endothelin-1 and tumor necrosis factor-${\alpha}$. Br J Dermatol 1998;139:216-24. https://doi.org/10.1046/j.1365-2133.1998.02357.x
  16. Hachiya A, Kobayashi A, Yoshida Y, Kitahara T, Takema Y, Imokawa G. Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis. Am J Pathol 2004;165:2099-109. https://doi.org/10.1016/S0002-9440(10)63260-9
  17. Halaban R, Langdon R, Birchall N, Cuono C, Baird A, Scott G, Moellmann G, McGuire J. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988;107:1611-9. https://doi.org/10.1083/jcb.107.4.1611
  18. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004;17:96-110. https://doi.org/10.1111/j.1600-0749.2003.00126.x
  19. Yoshida A, Anand-Apte B, Zetter BR. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 1996;13:57-64. https://doi.org/10.3109/08977199609034566
  20. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A 1991;88:3739-43. https://doi.org/10.1073/pnas.88.9.3739
  21. Hirobe T, Shinpo T, Higuchi K, Sano T. Life cycle of human melanocytes is regulated by endothelin-1 and stem cell factor in synergy with cyclic AMP and basic fibroblast growth factor. J Dermatol Sci 2010;57:123-31. https://doi.org/10.1016/j.jdermsci.2009.11.006
  22. Dong L, Li Y, Cao J, Liu F, Pier E, Chen J, Xu Z, Chen C, Wang R, Cui R. FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription. Cell Death Differ 2011;19:616-22.
  23. Attele AS, Wu JA, Yuan C. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
  24. Yun TK. Brief introduction of Panax ginseng C.A. meyer. J Korean Med Sci 2001;16:S3-5. https://doi.org/10.3346/jkms.2001.16.S.S3
  25. Tang W, Eisenbrand G. Panax ginseng CA meyer. New York: Springer; 1992.
  26. Kaku T, Miyata T, Uruno T, Sako I, Kinoshita A. Chemico-pharmacological studies on saponins of Panax ginseng C.A. meyer. II. Pharmacological part. Arzneimittelforschung 1975;25:539-47.
  27. Fishbein AB, Wang C, Li X, Mehendale SR, Sun S, Aung HH, Yuan C. Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng. Arch Pharm Res 2009;32:505-13. https://doi.org/10.1007/s12272-009-1405-9
  28. Jeon C, Kang S, Park S, Lim K, Hwang KW, Min H. T cell stimulatory effects of Korean Red Ginseng through modulation of myeloid-derived suppressor cells. J Ginseng Res 2011;35:462-70. https://doi.org/10.5142/jgr.2011.35.4.462
  29. Vuksan V, Sung M, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee K, Leiter LA, Nam KY, Arnason JT. Korean Red Ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008;18:46-56. https://doi.org/10.1016/j.numecd.2006.04.003
  30. Choi HK, Seong DH, Rha KH. Clinical efficacy of Korean Red Ginseng for erectile dysfunction. Int J Impot Res 1995;7:181-6.
  31. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 2004;10:RA187-92.
  32. Radad K, Gille G, Moldzio R, Saito H, Rausch W. Ginsenosides rb1 and rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res 2004;1021:41-53. https://doi.org/10.1016/j.brainres.2004.06.030
  33. Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I, Shinomiya N. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 1998;89:733-40. https://doi.org/10.1111/j.1349-7006.1998.tb03278.x
  34. Kim HS, Kim DH, Kim BK, Yoon SK, Kim MH, Lee JY, Kim HO, Park YM. Effects of topically applied Korean Red Ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/nga mice. Int Immunopharmacol 2011;11:280-5. https://doi.org/10.1016/j.intimp.2010.11.022
  35. Kimura Y, Sumiyoshi M, Kawahira K, Sakanaka M. Effects of ginseng saponins isolated from red ginseng roots on burn wound healing in mice. Br J Pharmacol 2006;148:860-70.
  36. Bae E, Han MJ, Shin Y, Kim D. Inhibitory effects of Korean Red Ginseng and its genuine constituents ginsenosides Rg3, rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol Pharm Bull 2006;29:1862-7. https://doi.org/10.1248/bpb.29.1862
  37. Muller M, Obeyesekere M, Mills GB, Ram PT. Network topology determines dynamics of the mammalian MAPK1,2 signaling network: Bifan motif regulation of C-raf and B-raf isoforms by FGFR and MC1R. FASEB J 2008;22:1393-403. https://doi.org/10.1096/fj.07-9100com
  38. Goding CR. MITF from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000;14:1712-28.
  39. Oh CT, Park JI, Jung YR, Joo YA, Shin DH, Cho HJ, Ahn SM, Lim Y, Park CK, Hwang JS. Inhibitory effect of Korean Red Ginseng on melanocyte proliferation and its possible implication in GM-CSF mediated signaling. J Ginseng Res 2013;37:389-400. https://doi.org/10.5142/jgr.2013.37.389
  40. Xie J, Mehendale SR, Li X, Quigg R, Wang X, Wang C, Wu JA, Aung HH. A Rue P, Bell GI. Antidiabetic effect of ginsenoside RE in ob/ob mice. Biochim Biophys Acta 2005;1740:319-25. https://doi.org/10.1016/j.bbadis.2004.10.010
  41. Cheng Y, Zhang J. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005;26:143-9. https://doi.org/10.1111/j.1745-7254.2005.00034.x
  42. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 2004;133:113-20. https://doi.org/10.1159/000076383
  43. Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, Fisher DE. C-kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor mi. Genes Dev 2000;14:301-12.
  44. Chung IR, Lee JE, Park YS, Lim YJ, Chang DH, Park JI, Hwang JS. Inhibitory mechanism of Korean Red Ginseng on GM-CSF expression in UVB-irradiated keratinocytes. J Ginseng Res 2015;39:322-30. https://doi.org/10.1016/j.jgr.2015.03.001

Cited by

  1. Protective action of the ginsenoside Rh3 in a rat myocardial ischemia-reperfusion injury model by inhibition of apoptosis induced via p38 mitogen-activated protein kinase/caspase-3 signaling vol.48, pp.12, 2017, https://doi.org/10.1177/0300060520969090
  2. The regulatory role of Korean ginseng in skin cells vol.45, pp.3, 2017, https://doi.org/10.1016/j.jgr.2020.08.004
  3. Basic fibroblast growth factor promotes human dental pulp stem cells cultured in 3D porous chitosan scaffolds to neural differentiation vol.131, pp.7, 2021, https://doi.org/10.1080/00207454.2020.1744592